IDO1 and depressive symptom measurement: IFN triggers the induction of indolamine 2,3-dioxygenase (IDO) and results in higher tryptophan metabolism along the kynurenine pathway and less being available for conversion to 5-hydroxytryptophan that induces the serotonin pathway; decreased serotonin levels lead to depression.